1. Home
  2. NTHI vs MAPS Comparison

NTHI vs MAPS Comparison

Compare NTHI & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • MAPS
  • Stock Information
  • Founded
  • NTHI 2008
  • MAPS 2008
  • Country
  • NTHI United States
  • MAPS United States
  • Employees
  • NTHI N/A
  • MAPS N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • MAPS Computer Software: Prepackaged Software
  • Sector
  • NTHI Health Care
  • MAPS Technology
  • Exchange
  • NTHI Nasdaq
  • MAPS Nasdaq
  • Market Cap
  • NTHI 110.9M
  • MAPS 94.2M
  • IPO Year
  • NTHI N/A
  • MAPS N/A
  • Fundamental
  • Price
  • NTHI $5.12
  • MAPS $1.18
  • Analyst Decision
  • NTHI
  • MAPS Strong Buy
  • Analyst Count
  • NTHI 0
  • MAPS 1
  • Target Price
  • NTHI N/A
  • MAPS $2.61
  • AVG Volume (30 Days)
  • NTHI 320.0K
  • MAPS 1.4M
  • Earning Date
  • NTHI 01-01-0001
  • MAPS 08-07-2025
  • Dividend Yield
  • NTHI N/A
  • MAPS N/A
  • EPS Growth
  • NTHI N/A
  • MAPS N/A
  • EPS
  • NTHI N/A
  • MAPS 0.09
  • Revenue
  • NTHI $79,990.00
  • MAPS $183,681,000.00
  • Revenue This Year
  • NTHI N/A
  • MAPS N/A
  • Revenue Next Year
  • NTHI N/A
  • MAPS $10.22
  • P/E Ratio
  • NTHI N/A
  • MAPS $13.64
  • Revenue Growth
  • NTHI 13.52
  • MAPS 0.13
  • 52 Week Low
  • NTHI $3.20
  • MAPS $0.70
  • 52 Week High
  • NTHI $25.00
  • MAPS $1.65
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • MAPS 60.85
  • Support Level
  • NTHI N/A
  • MAPS $1.11
  • Resistance Level
  • NTHI N/A
  • MAPS $1.30
  • Average True Range (ATR)
  • NTHI 0.00
  • MAPS 0.09
  • MACD
  • NTHI 0.00
  • MAPS 0.04
  • Stochastic Oscillator
  • NTHI 0.00
  • MAPS 72.73

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About MAPS WM Technology Inc.

WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.

Share on Social Networks: